Cathepsin D Expression in Oral Squamous Cell Carcinoma and Cancer-Associated Fibroblasts: A Preliminary Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Cancer-associated fibroblasts (CAFs) are abundant in tumor microenvironments and interact with cancer cells to promote tumor proliferation in oral squamous cell carcinoma (OSCC). Cathepsin D (CTSD) is a soluble lysosomal aspartic endopeptidase involved in tumor proliferation and angiogenesis. In this preliminary study, we observed CTSD expression in OSCC and CAFs, postulating that CTSD might act as a bridge between OSCC and CAFs. Methods: Human epidermal keratinocytes (HEKs), OSCC, and immortalized human normal oral fibroblasts (hTERT-hNOFs) were used in this study. Additionally, we used hTERT-hNOFs transfected with an empty vector, WT (wild-type)-YAP (Yes-associated protein), and YAPS127A (YAP serine 127 to alanine). YAP127A hTERT-hNOFs activated fibroblasts similar to CAFs. To identify CTSD expression between OSCC and CAFs, conditioned medium (CM) was collected from each cell. Protein expression of CTSD was identified by western blotting. Results: To identify the expression of CTSD in fibroblasts stimulated by OSCC, we treated fibroblasts with CM from HEK and OSCC. Results indicated that hTERT-hNOFs with OSCC CM showed a weakly increased expression of CTSD compared to stimulation by HEK CM. This indicates that CAFs, YAPS127 hTRET-hNOFs, overexpress CTSD protein. HEK cells showed no CTSD expression, regardless of treatment with fibroblast CM, whereas OSCC highly expressed CTSD proteins compared with the CTSD expression in HEK cells. We also found that CTSD expression was unaffected by changes in transforming growth factor-β levels. Conclusion: This study proposes that CTSD might have potential as an interacting executor between OSCC and CAFs. Further studies are needed to investigate the role of CTSD in tumor and stromal cells.
Abstract
Background: Cancer-associated fibroblasts (CAFs) are abundant in tumor microenvironments and interact with cancer cells to promote tumor proliferation in oral squamous cell carcinoma (OSCC). Cathepsin D (CTSD) is a soluble lysosomal aspartic endopeptidase involved in tumor proliferation and angiogenesis. In this preliminary study, we observed CTSD expression in OSCC and CAFs, postulating that CTSD might act as a bridge between OSCC and CAFs. Methods: Human epidermal keratinocytes (HEKs), OSCC, and immortalized human normal oral fibroblasts (hTERT-hNOFs) were used in this study. Additionally, we used hTERT-hNOFs transfected with an empty vector, WT (wild-type)-YAP (Yes-associated protein), and YAPS127A (YAP serine 127 to alanine). YAP127A hTERT-hNOFs activated fibroblasts similar to CAFs. To identify CTSD expression between OSCC and CAFs, conditioned medium (CM) was collected from each cell. Protein expression of CTSD was identified by western blotting. Results: To identify the expression of CTSD in fibroblasts stimulated by OSCC, we treated fibroblasts with CM from HEK and OSCC. Results indicated that hTERT-hNOFs with OSCC CM showed a weakly increased expression of CTSD compared to stimulation by HEK CM. This indicates that CAFs, YAPS127 hTRET-hNOFs, overexpress CTSD protein. HEK cells showed no CTSD expression, regardless of treatment with fibroblast CM, whereas OSCC highly expressed CTSD proteins compared with the CTSD expression in HEK cells. We also found that CTSD expression was unaffected by changes in transforming growth factor-β levels. Conclusion: This study proposes that CTSD might have potential as an interacting executor between OSCC and CAFs. Further studies are needed to investigate the role of CTSD in tumor and stromal cells.
참고문헌 (17)
- Roghayyeh Baghban, "Tumor microenvironment complexity and therapeutic implications at a glance", Cell Communication and Signaling, 18(1), pp.59~ (2020), Springer Science and Business Media LLC[DOI]
- Kenneth C. Valkenburg, "Targeting the tumour stroma to improve cancer therapy", Nature Reviews Clinical Oncology, 15(6), pp.366~381 (2018), Springer Science and Business Media LLC[DOI]
- Raghu Kalluri, "Fibroblasts in cancer", Nature Reviews Cancer, 6(5), pp.392~401 (2006), Springer Science and Business Media LLC[DOI]
- Zehuan Liao, "Cancer-associated fibroblasts in tumor microenvironment – Accomplices in tumor malignancy", Cellular Immunology, 343, pp.103729~ (2019), Elsevier BV[DOI]
- A. Calon, "TGF-beta in CAF-mediated tumor growth and metastasis", Seminars in Cancer Biology, 25, pp.15~22 (2014), Elsevier BV[DOI]
- Valeska Hofmeister, "Anti-cancer therapies targeting the tumor stroma", Cancer Immunology, Immunotherapy, 57(1), pp.1~17 (2008), Springer Science and Business Media LLC[DOI]
- Jung Yoon Bae, "Reciprocal Interaction between Carcinoma-Associated Fibroblasts and Squamous Carcinoma Cells through Interleukin-1α Induces Cancer Progression", Neoplasia, 16(11), pp.928~938 (2014), Elsevier BV[DOI]
- Simian M, "The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells", Development, 128, pp.3117~3131 (2001)
- Oakley C. Olson, "Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response", Nature Reviews Cancer, 15(12), pp.712~729 (2015), Springer Science and Business Media LLC[DOI]
- Gaetano Leto, "Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications", Clinical & Experimental Metastasis, 21(2), pp.91~106 (2004), Springer Science and Business Media LLC[DOI]
- Yahya Ashraf, "Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies", Journal for ImmunoTherapy of Cancer, 7(1), pp.29~ (2019), BMJ[DOI]
- Kim DK, "Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts", PLoS One, 14, pp.e0214553~ (2019)[DOI]
- Fernando Calvo, "Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts", Nature Cell Biology, 15(6), pp.637~646 (2013), Springer Science and Business Media LLC[DOI]
- Neil A. Bhowmick, "TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia", Science, 303(5659), pp.848~851 (2004), American Association for the Advancement of Science (AAAS)[DOI]
- Mélanie Bruchard, "Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth", Nature Medicine, 19(1), pp.57~64 (2013), Springer Science and Business Media LLC[DOI]
- N. Heylen, "Fibroblasts capture cathepsin D secreted by breast cancer cells: Possible role in the regulation of the invasive process", International Journal of Oncology, 20, pp.761~767 (2002), Spandidos Publications[DOI]
- F Wang, "Transcriptional activation of cathepsin D gene expression by growth factors", Journal of Molecular Endocrinology, 24(2), pp.193~202 (2000), Bioscientifica[DOI]